Crispr Nuclease Crispr Overview Crispr Pam Sequence Crispr Plasmids Crispr Products Crispr Service Crispr Software Crispr Transfection Goat Hamster Insect Kangaroo Leech Listeria Orangutan pcr Pigeon Rat Yeast
Vector competence of human-biting ticks Ixodes scapularis, Amblyomma americanum and Dermacentor variabilis for Powassan virus
Background: Powassan virus (POWV; genus Flavivirus) is the only real North American member of the tick-borne encephalitis sero-complex and an growing public well being risk within the USA. Maintained in nature by Ixodes spp. ticks, POWV has additionally been remoted from species of different laborious tick genera, but it’s unclear if these species can function vectors. Dermacentor variabilis and Amblyomma americanum share geographic and ecologic overlap with Ixodes spp. ticks and POWV transmission foci, elevating the chance that POWV may develop into established in these tick species and resulting in vary enlargement and elevated human threat. Subsequently, we assessed the competency of Ixodes scapularis, D. variabilis and A. americanum for POWV lineage II (POWV II).
Strategies: Larvae from all three species had been co-infested on POWV-infected Balb/c mice. The engorged larvae had been allowed to molt to nymphs and screened for the presence of POWV II RNA by reverse transcription-qPCR. Eight contaminated nymphs from every species had been allowed to individually feed on a naïve mouse. Mice had been screened for the presence of POWV II RNA to find out an infection standing.
Outcomes: The outcomes demonstrated that larvae from all three tick species had been capable of effectively purchase POWV II by way of feeding on viremic mice, keep an infection by way of molting and successively transmit POWV to naïve mice on the nymphal stage at comparable charges throughout all three species.
Conclusions: Our findings reveal that non-Ixodes tick species can function competent vectors for POWV and spotlight the potential function of those species within the ecology and epidemiology of POWV. Future research analyzing the potential implications of those findings on POWV epidemiology and the adaptability of POWV in these new vectors are warranted.
Key phrases: Amblyomma americanum; Dermacentor variabilis; Ixodes scapularis; Powassan virus; Vector competence.
Sort-I IFN promotes humoral immunity in viral vector vaccination
Recombinant viral vectors are an necessary platform for vaccine supply. Our current examine has demonstrated distinct innate immune profiles in responding to viral vectors of various households (e.g., adenovirus vs. poxvirus): whereas human Ad5 vector is minimally innate immune stimulatory, the poxviral vector ALVAC induces robust innate response and stimulates type-I IFN and inflammasome activation. Nevertheless, influence of the innate immune signaling on vaccine-induced adaptive immunity in viral vector vaccination is much less clear. Right here, we confirmed that Modified Vaccinia Ankara (MVA), one other poxviral vector, stimulated type-I IFN response in innate immune cells by way of cGAS-STING. Utilizing MVA-HIV vaccine as a mannequin, we discovered that type-I IFN signaling promoted the technology of humoral immunity in MVA-HIV vaccination in vivo.
Following vaccination, type-I IFN receptor knockout (IFNAR1-/-) mice produced considerably decrease ranges of complete and HIV gp120-specific antibodies in comparison with the wild-type (WT) mice. In keeping with the antibody response, type-I IFN signaling deficiency additionally led to decreased ranges of plasma cells and memory-like B cells in comparison with these in WT mice. Moreover, evaluation of vaccine-induced CD4 T cells confirmed that type-I IFN signaling additionally promoted the technology of vaccine-specific CD4 T-cell response and T follicular helper (Tfh) response in mice. Collectively, our information point out a task of type-I IFN signaling in selling humoral immunity in poxviral vector vaccination. The examine means that modulating type-I IFN and its related innate immune pathways will doubtless have an effect on vaccine efficacy.
IMPORTANCE Viral vectors, together with MVA, are an necessary antigen supply platform and have been generally utilized in vaccine improvement. Understanding the innate host-viral vector interactions and its influence on vaccine-induced immunity is important however understudied. Utilizing MVA-HIV vaccination of WT and IFNAR1-/- mice as a mannequin, our examine reviews that type-I IFN signaling promotes humoral immunity in MVA vaccination, together with vaccine-induced antibody, B-cell, and Tfh responses. Findings of the current examine present insights not just for primary understanding of host-viral vector interactions, but additionally for enhancing vaccine design by doubtlessly modulating type-I IFN and its related innate immune pathways in viral vector vaccination.
Transduction of rat and human adipose-tissue derived mesenchymal stromal cells by adeno-associated viral vector serotype DJ
Ex vivo, gene remedy is a robust strategy holding nice guarantees for the therapy of each genetic and bought illnesses. Adeno-associated virus (AAV) vectors are a protected and environment friendly supply system for modification of mesenchymal stem cells (MSC) that would maximize their therapeutic advantages. Evaluation of MSC viability and purposeful exercise after an infection with new AAV serotypes is critical, attributable to AAV tropism to particular cell sorts.
We contaminated human and rat adipose-tissue MSC with hybrid AAV-DJ serotype vectors carrying GFP and SCF genes. GFP expression from AAV-DJ was about 1.5-fold superior to that noticed with AAV-2 and lasted for at the very least 21 days as was evaluated by movement cytometry and fluorescence microscopy. AAV-DJ proves to be appropriate for the an infection of rat and human MSC with an identical effectivity.
Contaminated MSC had been nonetheless viable however confirmed a 25-30% growth-rate slowdown. Furthermore, we discovered a rise of SERPINB2 mRNA expression in human MSC whereas expression of different oxidative stress markers and extracellular matrix proteins was not affected. These outcomes counsel that there’s a differential mobile response in MSC contaminated with AAV viral vectors, which must be taken into consideration as it might probably have an effect on the anticipated final result for the therapeutic software.
Plasticity of the lettuce infectious yellows virus minor coat protein (CPm) in mediating the foregut retention and transmission of a chimeric CPm mutant by whitefly vectors
Transmission of the crinivirus, lettuce infectious yellows virus (LIYV), is set by a minor coat protein (CPm)-mediated virion retention mechanism situated within the foregut of its whitefly vector. To higher perceive the features of LIYV CPm, chimeric CPm mutants engineered with totally different lengths of the LIYV CPm amino acid sequence and that of the crinivirus, lettuce chlorosis virus (LCV), had been constructed primarily based on bioinformatics and sequence alignment information. The 485 amino acid-long chimeric CPm of LIYV mutant, CPmP-1, incorporates 60 % (from place Three to 294) of LCV CPm amino acids.
The chimeric CPm of mutants CPmP-2, CPmP-Three and CPmP-Four incorporates 46 (place Three to 208), 51 (place Three to 238) and 41 % (place 261 to 442) of LCV CPm amino acids, respectively. All 4 mutants moved systemically, expressed the chimeric CPm and shaped virus particles.
Nevertheless, following acquisition feeding of the virus preparations, solely CPmP-1 was retained within the foreguts of a major variety of vectors and transmitted. In immuno-gold labelling transmission electron microscopy (IGL-TEM) evaluation, CPmP-1 particles had been distinctly labelled by antibodies directed in opposition to the LCV however not LIYV CPm. In distinction, CPmP-Four particles weren’t labelled by antibodies directed in opposition to the LCV or LIYV CPm, whereas CPmP-2 and -Three particles had been weakly labelled by anti-LIYV CPm however not anti-LCV CPm antibodies.
The distinctive antibody recognition and binding sample of CPmP-1 was additionally displayed within the foreguts of whitefly vectors that consumed CPmP-1 virions. These outcomes are in step with the speculation that the chimeric CPm of CPmP-1 is included into purposeful virions, with the LCV CPm area being doubtlessly uncovered on the floor and accessible to anti-LCV CPm antibodies.
 Anti-CD163 |
|||
| DB-045-RTU-15 | DB Biotech | 15 ml | EUR 424.8 |
|
Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use) |
|||
Anti-CD163 |
|||
| DB-045-RTU-7 | DB Biotech | 7 ml | EUR 277.2 |
|
Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use) |
|||
Anti-CD163 |
|||
| DB045RTU-15 | DB Biotech | 15 ml | EUR 424.8 |
|
Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use) |
|||
Anti-CD163 |
|||
| DB045RTU-7 | DB Biotech | 7 ml | EUR 277.2 |
|
Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use) |
|||
 ELISA Kit) Mouse Cluster Of Differentiation (CD163) ELISA Kit |
|||
| DLR-CD163-Mu-48T | DL Develop | 48T | EUR 609.6 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Cluster Of Differentiation (CD163) in samples from serum, plasma or other biological fluids. |
|||
Mouse Cluster Of Differentiation (CD163) ELISA Kit |
|||
| DLR-CD163-Mu-96T | DL Develop | 96T | EUR 793.2 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Cluster Of Differentiation (CD163) in samples from serum, plasma or other biological fluids. |
|||
 ELISA Kit) Rat Cluster Of Differentiation (CD163) ELISA Kit |
|||
| DLR-CD163-Ra-48T | DL Develop | 48T | EUR 609.6 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Rat Cluster Of Differentiation (CD163) in samples from serum, plasma, tissue homogenates or other biological fluids. |
|||
Rat Cluster Of Differentiation (CD163) ELISA Kit |
|||
| DLR-CD163-Ra-96T | DL Develop | 96T | EUR 793.2 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Rat Cluster Of Differentiation (CD163) in samples from serum, plasma, tissue homogenates or other biological fluids. |
|||
Mouse Cluster Of Differentiation (CD163) ELISA Kit |
|||
| RDR-CD163-Mu-48Tests | Reddot Biotech | 48 Tests | EUR 640.8 |
Mouse Cluster Of Differentiation (CD163) ELISA Kit |
|||
| RDR-CD163-Mu-96Tests | Reddot Biotech | 96 Tests | EUR 890.4 |
Rat Cluster Of Differentiation (CD163) ELISA Kit |
|||
| RDR-CD163-Ra-48Tests | Reddot Biotech | 48 Tests | EUR 640.8 |
Rat Cluster Of Differentiation (CD163) ELISA Kit |
|||
| RDR-CD163-Ra-96Tests | Reddot Biotech | 96 Tests | EUR 890.4 |
Mouse Cluster Of Differentiation (CD163) ELISA Kit |
|||
| RD-CD163-Mu-48Tests | Reddot Biotech | 48 Tests | EUR 613.2 |
Mouse Cluster Of Differentiation (CD163) ELISA Kit |
|||
| RD-CD163-Mu-96Tests | Reddot Biotech | 96 Tests | EUR 850.8 |
Rat Cluster Of Differentiation (CD163) ELISA Kit |
|||
| RD-CD163-Ra-48Tests | Reddot Biotech | 48 Tests | EUR 613.2 |
Rat Cluster Of Differentiation (CD163) ELISA Kit |
|||
| RD-CD163-Ra-96Tests | Reddot Biotech | 96 Tests | EUR 850.8 |
 Rabbit Polyclonal antibody Anti-CRBN |
|||
| Anti-CRBN | ImmunoStep | 50 µg | EUR 418.8 |
 Anti-CD163 Antibody |
|||
| A00812-1 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-CD163 Antibody |
|||
| PA1874 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-CD163 Antibody |
|||
| PA1874-1 | BosterBio | 100ug/vial | EUR 400.8 |
 Anti-CD163 antibody |
|||
| STJ110681 | St John's Laboratory | 100 µl | EUR 332.4 |
|
Description: The protein encoded by this gene is a member of the scavenger receptor cysteine-rich (SRCR) superfamily, and is exclusively expressed in monocytes and macrophages. It functions as an acute phase-regulated receptor involved in the clearance and endocytosis of hemoglobin/haptoglobin complexes by macrophages, and may thereby protect tissues from free hemoglobin-mediated oxidative damage. This protein may also function as an innate immune sensor for bacteria and inducer of local inflammation. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. |
|||
Anti-CD163 Antibody |
|||
| STJ500423 | St John's Laboratory | 100 µg | EUR 571.2 |
Anti-CD163 Antibody |
|||
| STJ500424 | St John's Laboratory | 100 µg | EUR 571.2 |
Anti-CD163 antibody |
|||
| STJ160082 | St John's Laboratory | 1 mL C | EUR 1129.2 |
Anti-CD163 antibody |
|||
| STJ16100302 | St John's Laboratory | 100 µg | EUR 864 |
Anti-CD163 antibody |
|||
| STJ16100324 | St John's Laboratory | 1 mL | EUR 1174.8 |
 Anti-CD163 antibody |
|||
| STJ180301 | St John's Laboratory | 0.1 ml | EUR 258 |
Anti-CD163 antibody |
|||
| STJ190009 | St John's Laboratory | 200 µl | EUR 236.4 |
|
Description: Unconjugated Mouse monoclonal to CD163 (AS1A1) |
|||
ISA kit) Human CD163 antigen(CD163)ISA kit |
|||
| GA-E0263HM-48T | GenAsia Biotech | 48T | EUR 346.8 |
Human CD163 antigen(CD163)ISA kit |
|||
| GA-E0263HM-96T | GenAsia Biotech | 96T | EUR 559.2 |
 human CD163 antigen,CD163 LISA kit |
|||
| 201-12-0247 | SunredBio | 96 tests | EUR 528 |
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
|||
Human CD163 antigen(CD163)ISA kit |
|||
| QY-E05066 | Qayee Biotechnology | 96T | EUR 433.2 |
 human CD163 antigen,CD163 ELISA kit |
|||
| YLA0098HU-48T | Shanghai YL Biotech | 48T | EUR 435 |
human CD163 antigen,CD163 ELISA kit |
|||
| YLA0098HU-96T | Shanghai YL Biotech | 96T | EUR 562.5 |
 Anti-Hu CD163 PE |
|||
| 1P-645-T025 | ExBio | 25 tests | EUR 168 |
Anti-Hu CD163 PE |
|||
| 1P-645-T100 | ExBio | 100 tests | EUR 288 |
 Anti-Hu CD163 Purified |
|||
| 11-645-C025 | ExBio | 0.025 mg | EUR 118.8 |
Anti-Hu CD163 Purified |
|||
| 11-645-C100 | ExBio | 0.1 mg | EUR 189.6 |
 Anti-Hu CD163 APC |
|||
| 1A-645-T025 | ExBio | 25 tests | EUR 168 |
Anti-Hu CD163 APC |
|||
| 1A-645-T100 | ExBio | 100 tests | EUR 288 |
 Anti-CD163/M130 Antibody |
|||
| A00812 | BosterBio | 100ul | EUR 476.4 |
|
Description: Rabbit IgG polyclonal antibody for Scavenger receptor cysteine-rich type 1 protein M130 (CD163) detection.tested for IF, IHC, WB in Human, Mouse, Rat. Various direct flourescent conjugates are available for FCM upon request. Please contact us for details. |
|||
 anti- CD163/M130 Antibody |
|||
| FNab09771 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against CD163/M130 |
|||
 Anti-CD163/M130 antibody |
|||
| PAab09771 | Lifescience Market | 100 ug | EUR 426 |
 Anti-CD163 Antibody BIOTIN |
|||
| STJ500425 | St John's Laboratory | 100 µg | EUR 703.2 |
 Anti-CD163 Antibody FITC |
|||
| STJ500426 | St John's Laboratory | 100 µg | EUR 703.2 |
Anti-CD163 Antibody BIOTIN |
|||
| STJ500427 | St John's Laboratory | 100 µg | EUR 703.2 |
Anti-CD163 Antibody FITC |
|||
| STJ500428 | St John's Laboratory | 100 µg | EUR 703.2 |
 Mouse Anti Human Cd163 Monoclonal Antibody |
|||
| CABT-47162MH | Creative Diagnostics | 25 µg | EUR 446.4 |
Mouse Anti Human Cd163 Monoclonal Antibody |
|||
| CABT-47163MH | Creative Diagnostics | 0.2 mg | EUR 1057.2 |
 Polyclonal Goat anti-GST α-form |
|||
| GST-ANTI-1 | Detroit R&D | 50 uL | EUR 336 |
 Polyclonal Goat anti-GST μ-form |
|||
| GST-ANTI-2 | Detroit R&D | 50 uL | EUR 336 |
 Polyclonal Goat anti-GST p-form |
|||
| GST-ANTI-3 | Detroit R&D | 50 uL | EUR 336 |
 Anti-CD163 Rabbit Monoclonal Antibody |
|||
| M00812 | BosterBio | 100ug/vial | EUR 476.4 |
|
Description: Rabbit Monoclonal CD163 Antibody. Validated in IP, WB and tested in Human. |
|||
 Anti-Hu CD163 PE-Cy7 |
|||
| T7-645-T025 | ExBio | 25 tests | EUR 184.8 |
Anti-Hu CD163 PE-Cy7 |
|||
| T7-645-T100 | ExBio | 100 tests | EUR 321.6 |
 Anti-Hu CD163 PerCP-Cy5.5 |
|||
| T9-645-T025 | ExBio | 25 tests | EUR 235.2 |
Anti-Hu CD163 PerCP-Cy5.5 |
|||
| T9-645-T100 | ExBio | 100 tests | EUR 422.4 |
 Purified Anti-human CD163 Antibody *GHI/61* |
|||
| 11630000 | AAT Bioquest | 100 ug | EUR 365 |
 APC Anti-human CD163 Antibody *GHI/61* |
|||
| 116301B0 | AAT Bioquest | 25 tests | EUR 383 |
APC Anti-human CD163 Antibody *GHI/61* |
|||
| 116301B1 | AAT Bioquest | 100 tests | EUR 995 |
APC Anti-human CD163 Antibody *GHI/61* |
|||
| 116301B2 | AAT Bioquest | 500 tests | EUR 2984 |
 FITC Anti-human CD163 Antibody *GHI/61* |
|||
| 116301G0 | AAT Bioquest | 100 tests | EUR 547 |
FITC Anti-human CD163 Antibody *GHI/61* |
|||
| 116301G1 | AAT Bioquest | 500 tests | EUR 2051 |
 TRITC Anti-human CD163 Antibody *GHI/61* |
|||
| 116301H0 | AAT Bioquest | 100 tests | EUR 547 |
TRITC Anti-human CD163 Antibody *GHI/61* |
|||
| 116301H1 | AAT Bioquest | 500 tests | EUR 2051 |
 PacBlue Anti-human CD163 Antibody *GHI/61* |
|||
| 116301I0 | AAT Bioquest | 100 tests | EUR 547 |
PacBlue Anti-human CD163 Antibody *GHI/61* |
|||
| 116301I1 | AAT Bioquest | 500 tests | EUR 2051 |
 PacOrange Anti-human CD163 Antibody *GHI/61* |
|||
| 116301J0 | AAT Bioquest | 100 tests | EUR 547 |
PacOrange Anti-human CD163 Antibody *GHI/61* |
|||
| 116301J1 | AAT Bioquest | 500 tests | EUR 2051 |
 PE Anti-human CD163 Antibody *GHI/61* |
|||
| 116301K0 | AAT Bioquest | 25 tests | EUR 383 |
PE Anti-human CD163 Antibody *GHI/61* |
|||
| 116301K1 | AAT Bioquest | 100 tests | EUR 995 |
PE Anti-human CD163 Antibody *GHI/61* |
|||
| 116301K2 | AAT Bioquest | 500 tests | EUR 2984 |
 PerCP Anti-human CD163 Antibody *GHI/61* |
|||
| 116301S0 | AAT Bioquest | 25 tests | EUR 383 |
PerCP Anti-human CD163 Antibody *GHI/61* |
|||
| 116301S1 | AAT Bioquest | 100 tests | EUR 995 |
PerCP Anti-human CD163 Antibody *GHI/61* |
|||
| 116301S2 | AAT Bioquest | 500 tests | EUR 2984 |
 Canine CD163 antigen(CD163 LISA kit |
|||
| GA-E0062CN-48T | GenAsia Biotech | 48T | EUR 482.4 |
Canine CD163 antigen(CD163 LISA kit |
|||
| GA-E0062CN-96T | GenAsia Biotech | 96T | EUR 820.8 |
 Porcine CD163 antigen,CD163 LISA kit |
|||
| GA-E0045PC-48T | GenAsia Biotech | 48T | EUR 436.8 |
Porcine CD163 antigen,CD163 LISA kit |
|||
| GA-E0045PC-96T | GenAsia Biotech | 96T | EUR 708 |
Porcine CD163 antigen,CD163 LISA kit |
|||
| YLA0139PO-48T | Shanghai YL Biotech | 48T | EUR 502.5 |
Porcine CD163 antigen,CD163 LISA kit |
|||
| YLA0139PO-96T | Shanghai YL Biotech | 96T | EUR 618.75 |
 CD163 Antibody |
|||
| 1-CSB-PA969205 | Cusabio |
|
|
|
Description: A polyclonal antibody against CD163. Recognizes CD163 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:2000, IHC:1:25-1:100 |
|||
CD163 Antibody |
|||
| DF8235 | Affbiotech | 200ul | EUR 420 |
 CD163 siRNA |
|||
| 20-abx910930 | Abbexa |
|
|
CD163 siRNA |
|||
| 20-abx910931 | Abbexa |
|
|
 Cd163 Antibody |
|||
| 1-CSB-PA650452LA01MO | Cusabio |
|
|
|
Description: A polyclonal antibody against Cd163. Recognizes Cd163 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB; Recommended dilution: WB:1:500-1:2000 |
|||
CD163 Antibody |
|||
| 1-CSB-PA801238LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against CD163. Recognizes CD163 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IF; Recommended dilution: IF:1:50-1:200 |
|||
CD163 Antibody |
|||
| 49553-100ul | SAB | 100ul | EUR 399.6 |
CD163 Antibody |
|||
| 49553-50ul | SAB | 50ul | EUR 286.8 |
 CD163 Antibody |
|||
| 37157-100ul | SAB | 100ul | EUR 302.4 |
 CD163 antibody |
|||
| 10R-6496 | Fitzgerald | 100 ug | EUR 243.6 |
|
Description: Mouse monoclonal CD163 antibody |
|||
CD163 antibody |
|||
| 10R-CD163aRT | Fitzgerald | 250 ug | EUR 859.2 |
|
Description: Mouse monoclonal CD163 antibody |
|||
CD163 Antibody |
|||
| ABD8235 | Lifescience Market | 100 ug | EUR 525.6 |
CD163 Antibody |
|||
| 20-abx242956 | Abbexa |
|
|
CD163 Antibody |
|||
| R30973 | NSJ Bioreagents | 100 ug | EUR 419 |
CD163 Antibody |
|||
| R30974 | NSJ Bioreagents | 100 ug | EUR 419 |
CD163 Antibody |
|||
| RQ4259 | NSJ Bioreagents | 100 ug | EUR 419 |
CD163 Antibody |
|||
| V8227-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This MAb recognizes a protein of 140kDa, identified as CD163. It has been identified as an acute phase-regulated transmembrane protein whose function is to mediate the endocytosis of haptoglobin-hemoglobin complexes. This receptor is expressed on the surface of monocytes with low expression and on tissue macrophages, histiocytes with high expression. Staining with anti-CD163 has been helpful to distinguish synovial macrophages from synovial intimal fibroblasts in rheumatoid arthritis, where its specificity for macrophages was found to be superior to that of anti-CD68. Increased levels of CD163 were also detected in patients with microbial infections and myelomonocytic leukemias. Anti-CD163 is of considerable value for selective identification of monocytes and macrophages at a certain stage of differentiation and is suitable for diagnosing myelomonocytic or monocytic leukaemia and neoplasms of true histiocytic origin. CD163 is positive in skin (histiocytes), gut, Kupffer cells, a few alveolar macrophages, macrophages in the placenta, and in macrophages in inflamed tissues including tumor tissue. |
|||
CD163 Antibody |
|||
| V8227-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: This MAb recognizes a protein of 140kDa, identified as CD163. It has been identified as an acute phase-regulated transmembrane protein whose function is to mediate the endocytosis of haptoglobin-hemoglobin complexes. This receptor is expressed on the surface of monocytes with low expression and on tissue macrophages, histiocytes with high expression. Staining with anti-CD163 has been helpful to distinguish synovial macrophages from synovial intimal fibroblasts in rheumatoid arthritis, where its specificity for macrophages was found to be superior to that of anti-CD68. Increased levels of CD163 were also detected in patients with microbial infections and myelomonocytic leukemias. Anti-CD163 is of considerable value for selective identification of monocytes and macrophages at a certain stage of differentiation and is suitable for diagnosing myelomonocytic or monocytic leukaemia and neoplasms of true histiocytic origin. CD163 is positive in skin (histiocytes), gut, Kupffer cells, a few alveolar macrophages, macrophages in the placenta, and in macrophages in inflamed tissues including tumor tissue. |
|||
CD163 Antibody |
|||
| V8227SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This MAb recognizes a protein of 140kDa, identified as CD163. It has been identified as an acute phase-regulated transmembrane protein whose function is to mediate the endocytosis of haptoglobin-hemoglobin complexes. This receptor is expressed on the surface of monocytes with low expression and on tissue macrophages, histiocytes with high expression. Staining with anti-CD163 has been helpful to distinguish synovial macrophages from synovial intimal fibroblasts in rheumatoid arthritis, where its specificity for macrophages was found to be superior to that of anti-CD68. Increased levels of CD163 were also detected in patients with microbial infections and myelomonocytic leukemias. Anti-CD163 is of considerable value for selective identification of monocytes and macrophages at a certain stage of differentiation and is suitable for diagnosing myelomonocytic or monocytic leukaemia and neoplasms of true histiocytic origin. CD163 is positive in skin (histiocytes), gut, Kupffer cells, a few alveolar macrophages, macrophages in the placenta, and in macrophages in inflamed tissues including tumor tissue. |
|||
CD163 Antibody |
|||
| V8415-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This MAb recognizes a protein of 140kDa, identified as CD163. It has been identified as an acute phase-regulated transmembrane protein whose function is to mediate the endocytosis of haptoglobin-hemoglobin complexes. This receptor is expressed on the surface of monocytes with low expression and on tissue macrophages, histiocytes with high expression. Staining with anti-CD163 has been helpful to distinguish synovial macrophages from synovial intimal fibroblasts in rheumatoid arthritis, where its specificity for macrophages was found to be superior to that of anti-CD68. Increased levels of CD163 were also detected in patients with microbial infections and myelomonocytic leukemias. Anti-CD163 is of considerable value for selective identification of monocytes and macrophages at a certain stage of differentiation and is suitable for diagnosing myelomonocytic or monocytic leukaemia and neoplasms of true histiocytic origin. CD163 is positive in skin (histiocytes), gut, Kupffer cells, a few alveolar macrophages, macrophages in the placenta, and in macrophages in inflamed tissues including tumor tissue. |
|||
CD163 Antibody |
|||
| V8415-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: This MAb recognizes a protein of 140kDa, identified as CD163. It has been identified as an acute phase-regulated transmembrane protein whose function is to mediate the endocytosis of haptoglobin-hemoglobin complexes. This receptor is expressed on the surface of monocytes with low expression and on tissue macrophages, histiocytes with high expression. Staining with anti-CD163 has been helpful to distinguish synovial macrophages from synovial intimal fibroblasts in rheumatoid arthritis, where its specificity for macrophages was found to be superior to that of anti-CD68. Increased levels of CD163 were also detected in patients with microbial infections and myelomonocytic leukemias. Anti-CD163 is of considerable value for selective identification of monocytes and macrophages at a certain stage of differentiation and is suitable for diagnosing myelomonocytic or monocytic leukaemia and neoplasms of true histiocytic origin. CD163 is positive in skin (histiocytes), gut, Kupffer cells, a few alveolar macrophages, macrophages in the placenta, and in macrophages in inflamed tissues including tumor tissue. |
|||
CD163 Antibody |
|||
| V8415SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This MAb recognizes a protein of 140kDa, identified as CD163. It has been identified as an acute phase-regulated transmembrane protein whose function is to mediate the endocytosis of haptoglobin-hemoglobin complexes. This receptor is expressed on the surface of monocytes with low expression and on tissue macrophages, histiocytes with high expression. Staining with anti-CD163 has been helpful to distinguish synovial macrophages from synovial intimal fibroblasts in rheumatoid arthritis, where its specificity for macrophages was found to be superior to that of anti-CD68. Increased levels of CD163 were also detected in patients with microbial infections and myelomonocytic leukemias. Anti-CD163 is of considerable value for selective identification of monocytes and macrophages at a certain stage of differentiation and is suitable for diagnosing myelomonocytic or monocytic leukaemia and neoplasms of true histiocytic origin. CD163 is positive in skin (histiocytes), gut, Kupffer cells, a few alveolar macrophages, macrophages in the placenta, and in macrophages in inflamed tissues including tumor tissue. |
|||
CD163 Antibody |
|||
| F50316-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 165 |
CD163 Antibody |
|||
| F50316-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 379 |
CD163 Antibody |
|||
| V3937-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody recognizes a protein of 140kDa, identified as CD163. It has been identified as an acute phase-regulated transmembrane protein whose function is to mediate the endocytosis of haptoglobin-hemoglobin complexes. This receptor is expressed on the surface of monocytes with low expression and on tissue macrophages, histiocytes with high expression. Staining with anti-CD163 has been helpful to distinguish synovial macrophages from synovial intimal fibroblasts in rheumatoid arthritis, where its specificity for macrophages was found to be superior to that of anti-CD68. Increased levels of CD163 were also detected in patients with microbial infections and myelomonocytic leukemias. Anti-CD163 is of considerable value for selective identification of monocytes and macrophages at a certain stage of differentiation and is suitable for diagnosing myelomonocytic or monocytic leukaemia and neoplasms of true histiocytic origin. CD163 is positive in skin (histiocytes), gut, Kupffer cells, a few alveolar macrophages, macrophages in the placenta, and in macrophages in inflamed tissues including tumor tissue. |
|||
CD163 Antibody |
|||
| V3937-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: This antibody recognizes a protein of 140kDa, identified as CD163. It has been identified as an acute phase-regulated transmembrane protein whose function is to mediate the endocytosis of haptoglobin-hemoglobin complexes. This receptor is expressed on the surface of monocytes with low expression and on tissue macrophages, histiocytes with high expression. Staining with anti-CD163 has been helpful to distinguish synovial macrophages from synovial intimal fibroblasts in rheumatoid arthritis, where its specificity for macrophages was found to be superior to that of anti-CD68. Increased levels of CD163 were also detected in patients with microbial infections and myelomonocytic leukemias. Anti-CD163 is of considerable value for selective identification of monocytes and macrophages at a certain stage of differentiation and is suitable for diagnosing myelomonocytic or monocytic leukaemia and neoplasms of true histiocytic origin. CD163 is positive in skin (histiocytes), gut, Kupffer cells, a few alveolar macrophages, macrophages in the placenta, and in macrophages in inflamed tissues including tumor tissue. |
|||
CD163 Antibody |
|||
| V3937SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody recognizes a protein of 140kDa, identified as CD163. It has been identified as an acute phase-regulated transmembrane protein whose function is to mediate the endocytosis of haptoglobin-hemoglobin complexes. This receptor is expressed on the surface of monocytes with low expression and on tissue macrophages, histiocytes with high expression. Staining with anti-CD163 has been helpful to distinguish synovial macrophages from synovial intimal fibroblasts in rheumatoid arthritis, where its specificity for macrophages was found to be superior to that of anti-CD68. Increased levels of CD163 were also detected in patients with microbial infections and myelomonocytic leukemias. Anti-CD163 is of considerable value for selective identification of monocytes and macrophages at a certain stage of differentiation and is suitable for diagnosing myelomonocytic or monocytic leukaemia and neoplasms of true histiocytic origin. CD163 is positive in skin (histiocytes), gut, Kupffer cells, a few alveolar macrophages, macrophages in the placenta, and in macrophages in inflamed tissues including tumor tissue. |
|||
CD163 Antibody |
|||
| V7470-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody recognizes a protein of 140kDa, identified as CD163. It has been identified as an acute phase-regulated transmembrane protein whose function is to mediate the endocytosis of haptoglobin-hemoglobin complexes. This receptor is expressed on the surface of monocytes with low expression and on tissue macrophages, histiocytes with high expression. Staining with anti-CD163 has been helpful to distinguish synovial macrophages from synovial intimal fibroblasts in rheumatoid arthritis, where its specificity for macrophages was found to be superior to that of anti-CD68. Increased levels of CD163 were also detected in patients with microbial infections and myelomonocytic leukemias. Anti-CD163 is of considerable value for selective identification of monocytes and macrophages at a certain stage of differentiation and is suitable for diagnosing myelomonocytic or monocytic leukaemia and neoplasms of true histiocytic origin. CD163 is positive in skin (histiocytes), gut, Kupffer cells, a few alveolar macrophages, macrophages in the placenta, and in macrophages in inflamed tissues including tumor tissue. |
|||
CD163 Antibody |
|||
| V7470-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: This antibody recognizes a protein of 140kDa, identified as CD163. It has been identified as an acute phase-regulated transmembrane protein whose function is to mediate the endocytosis of haptoglobin-hemoglobin complexes. This receptor is expressed on the surface of monocytes with low expression and on tissue macrophages, histiocytes with high expression. Staining with anti-CD163 has been helpful to distinguish synovial macrophages from synovial intimal fibroblasts in rheumatoid arthritis, where its specificity for macrophages was found to be superior to that of anti-CD68. Increased levels of CD163 were also detected in patients with microbial infections and myelomonocytic leukemias. Anti-CD163 is of considerable value for selective identification of monocytes and macrophages at a certain stage of differentiation and is suitable for diagnosing myelomonocytic or monocytic leukaemia and neoplasms of true histiocytic origin. CD163 is positive in skin (histiocytes), gut, Kupffer cells, a few alveolar macrophages, macrophages in the placenta, and in macrophages in inflamed tissues including tumor tissue. |
|||
CD163 Antibody |
|||
| V7470IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
|
Description: This antibody recognizes a protein of 140kDa, identified as CD163. It has been identified as an acute phase-regulated transmembrane protein whose function is to mediate the endocytosis of haptoglobin-hemoglobin complexes. This receptor is expressed on the surface of monocytes with low expression and on tissue macrophages, histiocytes with high expression. Staining with anti-CD163 has been helpful to distinguish synovial macrophages from synovial intimal fibroblasts in rheumatoid arthritis, where its specificity for macrophages was found to be superior to that of anti-CD68. Increased levels of CD163 were also detected in patients with microbial infections and myelomonocytic leukemias. Anti-CD163 is of considerable value for selective identification of monocytes and macrophages at a certain stage of differentiation and is suitable for diagnosing myelomonocytic or monocytic leukaemia and neoplasms of true histiocytic origin. CD163 is positive in skin (histiocytes), gut, Kupffer cells, a few alveolar macrophages, macrophages in the placenta, and in macrophages in inflamed tissues including tumor tissue. |
|||
CD163 Antibody |
|||
| V7470SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody recognizes a protein of 140kDa, identified as CD163. It has been identified as an acute phase-regulated transmembrane protein whose function is to mediate the endocytosis of haptoglobin-hemoglobin complexes. This receptor is expressed on the surface of monocytes with low expression and on tissue macrophages, histiocytes with high expression. Staining with anti-CD163 has been helpful to distinguish synovial macrophages from synovial intimal fibroblasts in rheumatoid arthritis, where its specificity for macrophages was found to be superior to that of anti-CD68. Increased levels of CD163 were also detected in patients with microbial infections and myelomonocytic leukemias. Anti-CD163 is of considerable value for selective identification of monocytes and macrophages at a certain stage of differentiation and is suitable for diagnosing myelomonocytic or monocytic leukaemia and neoplasms of true histiocytic origin. CD163 is positive in skin (histiocytes), gut, Kupffer cells, a few alveolar macrophages, macrophages in the placenta, and in macrophages in inflamed tissues including tumor tissue. |
|||
CD163 Antibody |
|||
| V8757-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: CD163 is a type I membrane protein, and is a member of the hemoglobin scavenger receptor cystein-rich superfamily. The protein is involved in the clearance of hemoglobin-haptoglobin complexes and is considered to have anti-inflammatory functions. CD163 expression is restricted to the monocytic/macrophage lineage. It is expressed by all circulating monocytes and by a majority of tissue macrophages, such as splenic dendrocytes, alveolar macrophages and Kupffer cells of the liver. It is not present in macrophages in the mantle zone and some of the germinal center cells in lymph follicles, nor in Langerhans cells and interdigitating reticulum cells. In tumor tissues, CD163 is found in almost all cases of acute myeloid leukemia with monocytoid differentiation and in the majority of cases of histiocytic sarcoma, littoral cell angioma, Rosai-Dorfman disease, Langerhans cell histiocytosis and typical and atypical fibrous histiocytoma. It is also expressed in some cases of dermatofibrosarcoma protuberans. CD163 can be used to detect cells of monocytic and histiocyte lineage in neoplastic and reactive lesions. It has been shown to be more sensitive than CD68 for the detection of macrophages and monocytic cells. It covers a similar, but not identical, spectrum of cells as CD68. |
|||
CD163 Antibody |
|||
| V8757-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: CD163 is a type I membrane protein, and is a member of the hemoglobin scavenger receptor cystein-rich superfamily. The protein is involved in the clearance of hemoglobin-haptoglobin complexes and is considered to have anti-inflammatory functions. CD163 expression is restricted to the monocytic/macrophage lineage. It is expressed by all circulating monocytes and by a majority of tissue macrophages, such as splenic dendrocytes, alveolar macrophages and Kupffer cells of the liver. It is not present in macrophages in the mantle zone and some of the germinal center cells in lymph follicles, nor in Langerhans cells and interdigitating reticulum cells. In tumor tissues, CD163 is found in almost all cases of acute myeloid leukemia with monocytoid differentiation and in the majority of cases of histiocytic sarcoma, littoral cell angioma, Rosai-Dorfman disease, Langerhans cell histiocytosis and typical and atypical fibrous histiocytoma. It is also expressed in some cases of dermatofibrosarcoma protuberans. CD163 can be used to detect cells of monocytic and histiocyte lineage in neoplastic and reactive lesions. It has been shown to be more sensitive than CD68 for the detection of macrophages and monocytic cells. It covers a similar, but not identical, spectrum of cells as CD68. |
|||
CD163 Antibody |
|||
| V8757SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: CD163 is a type I membrane protein, and is a member of the hemoglobin scavenger receptor cystein-rich superfamily. The protein is involved in the clearance of hemoglobin-haptoglobin complexes and is considered to have anti-inflammatory functions. CD163 expression is restricted to the monocytic/macrophage lineage. It is expressed by all circulating monocytes and by a majority of tissue macrophages, such as splenic dendrocytes, alveolar macrophages and Kupffer cells of the liver. It is not present in macrophages in the mantle zone and some of the germinal center cells in lymph follicles, nor in Langerhans cells and interdigitating reticulum cells. In tumor tissues, CD163 is found in almost all cases of acute myeloid leukemia with monocytoid differentiation and in the majority of cases of histiocytic sarcoma, littoral cell angioma, Rosai-Dorfman disease, Langerhans cell histiocytosis and typical and atypical fibrous histiocytoma. It is also expressed in some cases of dermatofibrosarcoma protuberans. CD163 can be used to detect cells of monocytic and histiocyte lineage in neoplastic and reactive lesions. It has been shown to be more sensitive than CD68 for the detection of macrophages and monocytic cells. It covers a similar, but not identical, spectrum of cells as CD68. |
|||
 Human CD163 shRNA Plasmid |
|||
| 20-abx956176 | Abbexa |
|
|
 Human CD163 ELISA Kit |
|||
| LF-EK50890 | Abfrontier | 1×96T | EUR 777.6 |
 Human CD163 ELISA Kit |
|||
| ELA-E1726h | Lifescience Market | 96 Tests | EUR 988.8 |
 Mouse Anti Rat Cd163 Monoclonal Antibody |
|||
| DMABT-47170MR | Creative Diagnostics | 0.25 mg | EUR 889.2 |
Mouse Anti Rat Cd163 Monoclonal Antibody |
|||
| DMABT-47171MR | Creative Diagnostics | 0.1 mg | EUR 670.8 |
 Mouse Anti-Human CD163 monoclonal antibody, clone JID274 |
|||
| CABT-L2938-100uL500uL | Creative Diagnostics | 100 uL, 500 uL | EUR 602.4 |
 Anti-Human CD163 DyLight® 488 conjugated Antibody |
|||
| A00812-Dyl488 | BosterBio | 100ug/vial | EUR 412.8 |
 Anti-Human CD163 DyLight® 550 conjugated Antibody |
|||
| A00812-Dyl550 | BosterBio | 100ug/vial | EUR 412.8 |
 APC/Cy7 Anti-human CD163 Antibody *GHI/61* |
|||
| 116301C0 | AAT Bioquest | 25 tests | EUR 429 |
APC/Cy7 Anti-human CD163 Antibody *GHI/61* |
|||
| 116301C1 | AAT Bioquest | 100 tests | EUR 1117 |
APC/Cy7 Anti-human CD163 Antibody *GHI/61* |
|||
| 116301C2 | AAT Bioquest | 500 tests | EUR 3351 |
 PE/Cy5 Anti-human CD163 Antibody *GHI/61* |
|||
| 116301L0 | AAT Bioquest | 25 tests | EUR 429 |
PE/Cy5 Anti-human CD163 Antibody *GHI/61* |
|||
| 116301L1 | AAT Bioquest | 100 tests | EUR 1117 |
PE/Cy5 Anti-human CD163 Antibody *GHI/61* |
|||
| 116301L2 | AAT Bioquest | 500 tests | EUR 3351 |
 PE/Cy7 Anti-human CD163 Antibody *GHI/61* |
|||
| 116301M0 | AAT Bioquest | 25 tests | EUR 429 |
PE/Cy7 Anti-human CD163 Antibody *GHI/61* |
|||
| 116301M1 | AAT Bioquest | 100 tests | EUR 1117 |
PE/Cy7 Anti-human CD163 Antibody *GHI/61* |
|||
| 116301M2 | AAT Bioquest | 500 tests | EUR 3351 |
 PerCP/Cy5.5 Anti-human CD163 Antibody *GHI/61* |
|||
| 116301T0 | AAT Bioquest | 25 tests | EUR 429 |
PerCP/Cy5.5 Anti-human CD163 Antibody *GHI/61* |
|||
| 116301T1 | AAT Bioquest | 100 tests | EUR 1117 |
PerCP/Cy5.5 Anti-human CD163 Antibody *GHI/61* |
|||
| 116301T2 | AAT Bioquest | 500 tests | EUR 3351 |
 Human CellExp? CD163, Human recombinant |
|||
| 9226-10 | Biovision | each | EUR 366 |
Human CellExp? CD163, Human recombinant |
|||
| 9226-50 | Biovision | each | EUR 927.6 |
 iFluor® 350 Anti-human CD163 Antibody *GHI/61* |
|||
| 11630010 | AAT Bioquest | 100 tests | EUR 547 |
iFluor® 350 Anti-human CD163 Antibody *GHI/61* |
|||
| 11630011 | AAT Bioquest | 500 tests | EUR 2051 |
 iFluor® 405 Anti-human CD163 Antibody *GHI/61* |
|||
| 11630020 | AAT Bioquest | 100 tests | EUR 547 |
iFluor® 405 Anti-human CD163 Antibody *GHI/61* |
|||
| 11630021 | AAT Bioquest | 500 tests | EUR 2051 |
 iFluor® 430 Anti-human CD163 Antibody *GHI/61* |
|||
| 11630030 | AAT Bioquest | 100 tests | EUR 547 |
iFluor® 430 Anti-human CD163 Antibody *GHI/61* |
|||
| 11630031 | AAT Bioquest | 500 tests | EUR 2051 |
 iFluor® 450 Anti-human CD163 Antibody *GHI/61* |
|||
| 11630040 | AAT Bioquest | 100 tests | EUR 547 |
iFluor® 450 Anti-human CD163 Antibody *GHI/61* |
|||
| 11630041 | AAT Bioquest | 500 tests | EUR 2051 |
 iFluor® 488 Anti-human CD163 Antibody *GHI/61* |
|||
| 11630050 | AAT Bioquest | 100 tests | EUR 547 |
iFluor® 488 Anti-human CD163 Antibody *GHI/61* |
|||
| 11630051 | AAT Bioquest | 500 tests | EUR 2051 |
 iFluor® 514 Anti-human CD163 Antibody *GHI/61* |
|||
| 11630060 | AAT Bioquest | 100 tests | EUR 547 |
iFluor® 514 Anti-human CD163 Antibody *GHI/61* |
|||
| 11630061 | AAT Bioquest | 500 tests | EUR 2051 |
 iFluor® 532 Anti-human CD163 Antibody *GHI/61* |
|||
| 11630070 | AAT Bioquest | 100 tests | EUR 547 |
iFluor® 532 Anti-human CD163 Antibody *GHI/61* |
|||
| 11630071 | AAT Bioquest | 500 tests | EUR 2051 |
 iFluor® 546 Anti-human CD163 Antibody *GHI/61* |
|||
| 11630080 | AAT Bioquest | 100 tests | EUR 547 |
iFluor® 546 Anti-human CD163 Antibody *GHI/61* |
|||
| 11630081 | AAT Bioquest | 500 tests | EUR 2051 |
 iFluor® 555 Anti-human CD163 Antibody *GHI/61* |
|||
| 11630090 | AAT Bioquest | 100 tests | EUR 547 |
iFluor® 555 Anti-human CD163 Antibody *GHI/61* |
|||
| 11630091 | AAT Bioquest | 500 tests | EUR 2051 |
 iFluor® 560 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300A0 | AAT Bioquest | 100 tests | EUR 547 |
iFluor® 560 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300A1 | AAT Bioquest | 500 tests | EUR 2051 |
 iFluor® 568 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300B0 | AAT Bioquest | 100 tests | EUR 547 |
iFluor® 568 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300B1 | AAT Bioquest | 500 tests | EUR 2051 |
 iFluor® 594 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300C0 | AAT Bioquest | 100 tests | EUR 547 |
iFluor® 594 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300C1 | AAT Bioquest | 500 tests | EUR 2051 |
 iFluor® 610 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300D0 | AAT Bioquest | 100 tests | EUR 547 |
iFluor® 610 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300D1 | AAT Bioquest | 500 tests | EUR 2051 |
 iFluor® 633 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300E0 | AAT Bioquest | 100 tests | EUR 547 |
iFluor® 633 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300E1 | AAT Bioquest | 500 tests | EUR 2051 |
 iFluor® 647 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300F0 | AAT Bioquest | 100 tests | EUR 547 |
iFluor® 647 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300F1 | AAT Bioquest | 500 tests | EUR 2051 |
 iFluor® 660 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300G0 | AAT Bioquest | 100 tests | EUR 547 |
iFluor® 660 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300G1 | AAT Bioquest | 500 tests | EUR 2051 |
 iFluor® 670 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300H0 | AAT Bioquest | 100 tests | EUR 547 |
iFluor® 670 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300H1 | AAT Bioquest | 500 tests | EUR 2051 |
 iFluor® 680 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300I0 | AAT Bioquest | 100 tests | EUR 547 |
iFluor® 680 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300I1 | AAT Bioquest | 500 tests | EUR 2051 |
 iFluor® 700 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300J0 | AAT Bioquest | 100 tests | EUR 547 |
iFluor® 700 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300J1 | AAT Bioquest | 500 tests | EUR 2051 |
 iFluor® 710 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300K0 | AAT Bioquest | 100 tests | EUR 547 |
iFluor® 710 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300K1 | AAT Bioquest | 500 tests | EUR 2051 |
 iFluor® 750 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300L0 | AAT Bioquest | 100 tests | EUR 547 |
iFluor® 750 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300L1 | AAT Bioquest | 500 tests | EUR 2051 |
 iFluor® 790 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300M0 | AAT Bioquest | 100 tests | EUR 547 |
iFluor® 790 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300M1 | AAT Bioquest | 500 tests | EUR 2051 |
 iFluor® 800 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300N0 | AAT Bioquest | 100 tests | EUR 547 |
iFluor® 800 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300N1 | AAT Bioquest | 500 tests | EUR 2051 |
 iFluor® 810 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300O0 | AAT Bioquest | 100 tests | EUR 547 |
iFluor® 810 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300O1 | AAT Bioquest | 500 tests | EUR 2051 |
 iFluor® 820 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300P0 | AAT Bioquest | 100 tests | EUR 547 |
iFluor® 820 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300P1 | AAT Bioquest | 500 tests | EUR 2051 |
 iFluor® 840 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300Q0 | AAT Bioquest | 100 tests | EUR 547 |
iFluor® 840 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300Q1 | AAT Bioquest | 500 tests | EUR 2051 |
 iFluor® 860 Anti-human CD163 Antibody *GHI/61* |
|||
| 116300R0 | AAT Bioquest | 100 tests | EUR 547 |
